NO20026280D0 - Melanokortin reseptor-ligander - Google Patents
Melanokortin reseptor-liganderInfo
- Publication number
- NO20026280D0 NO20026280D0 NO20026280A NO20026280A NO20026280D0 NO 20026280 D0 NO20026280 D0 NO 20026280D0 NO 20026280 A NO20026280 A NO 20026280A NO 20026280 A NO20026280 A NO 20026280A NO 20026280 D0 NO20026280 D0 NO 20026280D0
- Authority
- NO
- Norway
- Prior art keywords
- melanocortin receptor
- receptor ligand
- melanocortin
- het
- disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Child & Adolescent Psychology (AREA)
- Pregnancy & Childbirth (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21461600P | 2000-06-28 | 2000-06-28 | |
| PCT/IB2001/000995 WO2002000654A1 (en) | 2000-06-28 | 2001-05-31 | Melanocortin receptor ligands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20026280D0 true NO20026280D0 (no) | 2002-12-30 |
| NO20026280L NO20026280L (no) | 2002-12-30 |
Family
ID=22799775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20026280A NO20026280L (no) | 2000-06-28 | 2002-12-30 | Melanokortin reseptor-ligander |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US20020072604A1 (zh) |
| EP (1) | EP1294719A1 (zh) |
| JP (1) | JP2004501917A (zh) |
| KR (1) | KR20030017571A (zh) |
| CN (1) | CN1440406A (zh) |
| AP (1) | AP2001002196A0 (zh) |
| AR (1) | AR030301A1 (zh) |
| AU (1) | AU2001260548A1 (zh) |
| BG (1) | BG107268A (zh) |
| BR (1) | BR0111567A (zh) |
| CA (1) | CA2412563A1 (zh) |
| EA (1) | EA200201119A1 (zh) |
| EC (1) | ECSP024404A (zh) |
| IL (1) | IL152781A0 (zh) |
| IS (1) | IS6617A (zh) |
| MA (1) | MA26920A1 (zh) |
| MX (1) | MXPA03000063A (zh) |
| NO (1) | NO20026280L (zh) |
| OA (1) | OA12296A (zh) |
| PA (1) | PA8521501A1 (zh) |
| PE (1) | PE20020208A1 (zh) |
| PL (1) | PL360855A1 (zh) |
| TN (1) | TNSN01097A1 (zh) |
| UY (1) | UY26804A1 (zh) |
| WO (1) | WO2002000654A1 (zh) |
| ZA (1) | ZA200210277B (zh) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001264977B2 (en) * | 2000-05-30 | 2005-04-14 | Merck & Co., Inc. | Melanocortin receptor agonists |
| WO2002079146A2 (en) | 2001-03-02 | 2002-10-10 | Bristol-Myers Squibb Company | Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| US6911447B2 (en) * | 2001-04-25 | 2005-06-28 | The Procter & Gamble Company | Melanocortin receptor ligands |
| US7354923B2 (en) * | 2001-08-10 | 2008-04-08 | Palatin Technologies, Inc. | Piperazine melanocortin-specific compounds |
| CA2462200A1 (en) | 2001-08-10 | 2003-02-20 | Palatin Technologies, Inc. | Peptidomimetics of biologically active metallopeptides |
| US7732451B2 (en) * | 2001-08-10 | 2010-06-08 | Palatin Technologies, Inc. | Naphthalene-containing melanocortin receptor-specific small molecule |
| US7655658B2 (en) * | 2001-08-10 | 2010-02-02 | Palatin Technologies, Inc. | Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds |
| US7456184B2 (en) * | 2003-05-01 | 2008-11-25 | Palatin Technologies Inc. | Melanocortin receptor-specific compounds |
| US7718802B2 (en) | 2001-08-10 | 2010-05-18 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific piperazine compounds |
| US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
| UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
| US7084156B2 (en) | 2001-11-27 | 2006-08-01 | Merck & Co., Inc. | 2-Aminoquinoline compounds |
| US7026335B2 (en) | 2002-04-30 | 2006-04-11 | The Procter & Gamble Co. | Melanocortin receptor ligands |
| TW200504033A (en) | 2002-10-23 | 2005-02-01 | Procter & Gamble | Melanocortin receptor ligands |
| JPWO2004069798A1 (ja) | 2003-02-10 | 2006-05-25 | 萬有製薬株式会社 | ピペリジン誘導体を有効成分とするメラニン凝集ホルモン受容体拮抗剤 |
| US7968548B2 (en) | 2003-05-01 | 2011-06-28 | Palatin Technologies, Inc. | Melanocortin receptor-specific piperazine compounds with diamine groups |
| US7727990B2 (en) | 2003-05-01 | 2010-06-01 | Palatin Technologies, Inc. | Melanocortin receptor-specific piperazine and keto-piperazine compounds |
| US7727991B2 (en) | 2003-05-01 | 2010-06-01 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific single acyl piperazine compounds |
| US7795267B2 (en) | 2003-08-29 | 2010-09-14 | Takeda Pharmaceutical Company Limited | Bicyclic piperazine compound having TGR23 antagonistic activity |
| JP2005306839A (ja) * | 2003-08-29 | 2005-11-04 | Takeda Chem Ind Ltd | 二環性ピペラジン化合物およびその用途 |
| DE602005026380D1 (de) * | 2004-04-08 | 2011-03-31 | Astellas Pharma Inc | Verbindung ws727713 |
| US7709484B1 (en) | 2004-04-19 | 2010-05-04 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific piperazine compounds |
| KR101232201B1 (ko) * | 2005-07-08 | 2013-02-12 | 입센 파마 에스.에이.에스 | 멜라노코르틴 수용체 리간드 |
| ES2646326T3 (es) | 2005-08-03 | 2017-12-13 | Sprout Pharmaceuticals, Inc. | Uso de flibanserina en el tratamiento de la obesidad |
| CA2626134C (en) | 2005-10-29 | 2013-12-24 | Boehringer Ingelheim International Gmbh | Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
| PE20080145A1 (es) * | 2006-03-21 | 2008-02-11 | Janssen Pharmaceutica Nv | Tetrahidro-pirimidoazepinas como moduladores de trpv1 |
| DE602007004615D1 (de) | 2006-06-30 | 2010-03-18 | Boehringer Ingelheim Pharma | Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen |
| EP2039695A4 (en) | 2006-07-11 | 2010-09-15 | Takeda Pharmaceutical | BICYCLIC HETEROCYLIC COMPOUND AND ITS USE |
| US7834017B2 (en) | 2006-08-11 | 2010-11-16 | Palatin Technologies, Inc. | Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents |
| AR062320A1 (es) | 2006-08-14 | 2008-10-29 | Boehringer Ingelheim Int | Formulaciones de flibanserina y metodo para fabricarlas |
| EA200900270A1 (ru) | 2006-08-25 | 2009-08-28 | Бёрингер Ингельхайм Интернациональ Гмбх | Системы регулируемого высвобождения и способ их приготовления |
| CA2689016C (en) | 2007-05-25 | 2014-08-12 | Ipsen Pharma S.A.S. | Melanocortin receptor ligands modified with hydantoin |
| CL2008002693A1 (es) | 2007-09-12 | 2009-10-16 | Boehringer Ingelheim Int | Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad |
| US8288397B2 (en) | 2007-12-17 | 2012-10-16 | Janssen Pharmaceutica Nv | Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999055679A1 (en) * | 1998-04-28 | 1999-11-04 | Trega Biosciences, Inc. | Isoquinoline compound melanocortin receptor ligands and methods of using same |
| JP2002517444A (ja) * | 1998-06-11 | 2002-06-18 | メルク エンド カムパニー インコーポレーテッド | メラノコルチン受容体作動薬としてのスピロピペリジン誘導体 |
| EP1187614A4 (en) * | 1999-06-04 | 2005-06-22 | Merck & Co Inc | SUBSTITUTED PIPERIDINES THAN MELANOCORTIN-4 RECEPTOR AGONISTS |
-
2001
- 2001-05-31 IL IL15278101A patent/IL152781A0/xx unknown
- 2001-05-31 CA CA002412563A patent/CA2412563A1/en not_active Abandoned
- 2001-05-31 PL PL36085501A patent/PL360855A1/xx not_active Application Discontinuation
- 2001-05-31 EP EP01934254A patent/EP1294719A1/en not_active Withdrawn
- 2001-05-31 JP JP2002505778A patent/JP2004501917A/ja not_active Withdrawn
- 2001-05-31 OA OA1200200389A patent/OA12296A/en unknown
- 2001-05-31 AU AU2001260548A patent/AU2001260548A1/en not_active Abandoned
- 2001-05-31 CN CN01812163A patent/CN1440406A/zh active Pending
- 2001-05-31 AP APAP/P/2001/002196A patent/AP2001002196A0/en unknown
- 2001-05-31 KR KR1020027017822A patent/KR20030017571A/ko not_active Application Discontinuation
- 2001-05-31 EA EA200201119A patent/EA200201119A1/ru unknown
- 2001-05-31 BR BR0111567-7A patent/BR0111567A/pt not_active IP Right Cessation
- 2001-05-31 WO PCT/IB2001/000995 patent/WO2002000654A1/en not_active Application Discontinuation
- 2001-05-31 MX MXPA03000063A patent/MXPA03000063A/es unknown
- 2001-06-25 US US09/891,026 patent/US20020072604A1/en not_active Abandoned
- 2001-06-26 AR ARP010103037A patent/AR030301A1/es unknown
- 2001-06-26 PE PE2001000626A patent/PE20020208A1/es not_active Application Discontinuation
- 2001-06-27 TN TNTNSN01097A patent/TNSN01097A1/fr unknown
- 2001-06-27 UY UY26804A patent/UY26804A1/es not_active Application Discontinuation
- 2001-06-28 PA PA20018521501A patent/PA8521501A1/es unknown
-
2002
- 2002-11-12 BG BG107268A patent/BG107268A/xx unknown
- 2002-11-14 IS IS6617A patent/IS6617A/is unknown
- 2002-12-19 ZA ZA200210277A patent/ZA200210277B/en unknown
- 2002-12-24 MA MA26976A patent/MA26920A1/fr unknown
- 2002-12-26 EC EC2002004404A patent/ECSP024404A/es unknown
- 2002-12-30 NO NO20026280A patent/NO20026280L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR030301A1 (es) | 2003-08-20 |
| PL360855A1 (en) | 2004-09-20 |
| JP2004501917A (ja) | 2004-01-22 |
| IL152781A0 (en) | 2003-06-24 |
| MXPA03000063A (es) | 2003-09-25 |
| AU2001260548A1 (en) | 2002-01-08 |
| ZA200210277B (en) | 2003-12-19 |
| PE20020208A1 (es) | 2002-03-13 |
| CA2412563A1 (en) | 2002-01-03 |
| EA200201119A1 (ru) | 2003-06-26 |
| BG107268A (en) | 2003-06-30 |
| UY26804A1 (es) | 2002-01-31 |
| US20020072604A1 (en) | 2002-06-13 |
| MA26920A1 (fr) | 2004-12-20 |
| EP1294719A1 (en) | 2003-03-26 |
| KR20030017571A (ko) | 2003-03-03 |
| PA8521501A1 (es) | 2002-10-24 |
| IS6617A (is) | 2002-11-14 |
| BR0111567A (pt) | 2003-05-06 |
| NO20026280L (no) | 2002-12-30 |
| CN1440406A (zh) | 2003-09-03 |
| WO2002000654A1 (en) | 2002-01-03 |
| ECSP024404A (es) | 2003-02-06 |
| AP2001002196A0 (en) | 2002-12-21 |
| TNSN01097A1 (fr) | 2005-11-10 |
| OA12296A (en) | 2006-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20026280D0 (no) | Melanokortin reseptor-ligander | |
| NO20022318D0 (no) | Nye forbindelser | |
| EA200300528A1 (ru) | 1-арил-или 1-алкилсульфонилгетероциклилбензазолы в качестве лигандов 5-гидрокситриптамина-6 | |
| ATE355278T1 (de) | Isochinolinon derivate als parp inhibitoren | |
| NO20021358D0 (no) | Alkylendiamin-substituerte heterocykler | |
| ATE524184T1 (de) | 2,4-pyrimidindiamin-verbindungen und ihre verwendungszwecke | |
| DK0737194T3 (da) | Diazabicykliske neurokininantagonister | |
| DK1131315T3 (da) | Polyhydroxylerede heterocykliske derivater som antikoagulanter | |
| CY1106424T1 (el) | Παραγωγα ν-φαινυλ-πυρρολ γουανιδινης ως συνδετες υποδοχεις μελανοκορτινης | |
| ATE302770T1 (de) | Benzimidazolverbindungen die nociceptinrezeptoraffinität haben | |
| DE60129154D1 (de) | Neuartige verbindungen | |
| NO20015227D0 (no) | Fremgangsmåte for å öke effektiviteten til anti-cancer midler | |
| NO20072060L (no) | 2-acylaminotiazolderivater | |
| DE60233350D1 (de) | IMIDAZOi2,1-B -1,3,4-THIADIAZOLE SULFONAMIDES | |
| DK1305037T3 (da) | Smertestillende medikament | |
| MXPA04003544A (es) | Benzotriazepinas como ligandos del receptor de gastrina y colecistocinina. | |
| DE502004007387D1 (de) | Triazolverbindungen und ihre therapeutische verwendung | |
| TR200003203T2 (tr) | Karboksaldehitin saflaştırılması | |
| DOP2001000174A (es) | Ligandos para receptores de melanocortina | |
| ATE275551T1 (de) | Halogenpyrimidine | |
| EE200200215A (et) | 2-amino-3,4-dihüdrokinasoliinide kasutamine ravimi valmistamiseks, mis on ette nähtud isheemilistest seisunditest tingitud haiguste raviks või ennetamiseks | |
| BR0317377A (pt) | Derivados de 5-aminofenantridina como antagonistas de npy-5 | |
| ITRM20010136A0 (it) | Composti utili per il trattamento di patologie che rispondono all'attivazione del recettore ppar-gamma. | |
| SV2002000513A (es) | Ligandos para receptores de melanocortina ref.pc10861abtc/bb | |
| TR200103690T2 (tr) | IL-8 reseptör antagonistleri |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |